CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Xenon gasother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00934700
NCT00934700N/ACompleted
CompareCT.gov

Neuroprotective Effects of Hypothermia Combined With Inhaled Xenon Following Perinatal Asphyxia

Imperial College London·interventional·Posted Jul 8, 2009·Updated Apr 21, 2022

In Brief

A clinical study evaluating Xenon gas for Hypoxic Ischaemic Encephalopathy. Completed, enrolled 92 participants across 1 site.

Detailed Summary

This is a randomised controlled trial in newborn infants with perinatal asphyxial encephalopathy assessing whether a combination of hypothermia and inhaled xenon preserve cerebral metabolism and structure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoxic Ischaemic Encephalopathy
CountriesUnited Kingdom
CollaboratorsUniversity College London Hospitals, Guy's and St Thomas' NHS Foundation Trust

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 8, 2009
Enrollment StartFeb 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 17.0 years ago

Interventions

Xenon gasother

30% Xenon gas inhaled for 24 hours